• Escitalopram is a leading and growing product in Central Nervous system (CNS)
• This agreement reinforces Almirall?s portfolio in Italy and will generate revenues as of this year
• It is estimated that over 38% of the EU population suffers from a mental disorder. Depression is common, affecting about 121 million people worldwide

Barcelona and Milan, 19 October 2011,-Almirall, SpA and Lundbeck Italia, SpA today announced that they have entered into a co-promotion agreement for escitalopram in Italy under the brand Cipralex?

Escitalopram is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) family, indicated in treatment of depression and anxiety disorder.

Financial details of the agreement were not disclosed.

“We are very pleased with this new collaboration with Lundbeck. It strengthens our Italian portfolio with a leading and growing product and allows us to leverage our CNS capabilities and expertise?, said Javier Garc?a, General Manager Almirall Italy. ?This agreement reinforces Almirall?s position as a solid partner in Italy and will generate revenues as of this year?, he added.

“We are very happy at Lundbeck, says Ralph Fassey, General Manager of the Italian subsidiary, to have from now on with Almirall Italy a very valid and competent partner to co-promote our escitalopram, the already most prescribed antidepressant in our country. The?fruitful and long lasting collaboration between our two companies in Spain induced us to extend the cooperation to another important Mediterranean country such as, Italy.”

About escitalopramEscitalopram is one of the most?effective and tolerable molecules for the treatment of depression and anxiety. It acts increasing the level of?serotonin, a specific neurotransmitter,?whose reduction is involved in the onset of symptoms of these disorders. Escitalopram differs from the other antidepressants of the same class (SSRI) for a unique mechanism of action, responsible for its relevant clinical efficacy.

About depression and anxiety disorderDepression is a common mental disorder that presents with depressed mood, loss of interest or pleasure, feelings of guilt or low self-worth, disturbed sleep or appetite, low energy, and poor concentration. These problems can become chronic or recurrent and lead to substantial impairments in an individual’s ability to take care of his or her everyday responsibilities. At its worst, depression can lead to suicide, a tragic fatality associated with the loss of about 850 000 lives every year[1].

Depression is the leading cause of disability as measured by YLDs and the 4th?leading contributor to the global burden of disease (DALYs) in 2000. by the year 2020, depression is projected to reach 2nd place of the ranking of DALYs calculated for all ages, both sexes. Today, depression is already the 2nd cause of DALYs in the age category 15-44 years for both sexes combined[4].

Depression is common, affecting about 121 million people worldwide[2]. It occurs in persons of all genders, ages, and backgrounds.

It is estimated that each year 38.2% of the EU population suffers from a mental disorder[3]. Adjusted for age and co-morbidity, this corresponds to 164.8 million persons affected. Compared to 2005 (27.4%) this higher estimate is entirely due to the inclusion of 14 new disorders also covering childhood/adolescence as well as the elderly. The estimated higher number of persons affected (2011: 165 m vs. 2005: 82 m) is due to coverage of childhood and old age populations, new disorders and of new EU membership states. The most frequent disorders are anxiety disorders (14.0%), insomnia (7.0%), major depression (6.9%), somatoform (6.3%), alcohol and drug dependence (> 4%), ADHD (5%) in the young, and dementia (1?30%, depending on age).

About AlmirallAlmirall is an international pharmaceutical company based on innovation and committed to health. Headquartered in Barcelona, Spain, it researches, develops, manufactures and commercialises its own R&D and licensed drugs with the aim of improving people?s health and wellbeing.?

Almirall focuses its research resources on therapeutic areas related to the treatment of asthma, COPD (Chronic Obstructive Pulmonary Disease), gastrointestinal disorders, psoriasis and other dermatological conditions.

Almirall?s products are currently present in over 70 countries while it has direct presence in Europe and Latin America through 12 affiliates.

For further information please visit the website at: almirall.com

About LundbeckLundbeck is an international pharmaceutical company founded by Hans Lundbeck in 1915 specializing in central nervous system disorders, with its headquarter in Copenhagen, Denmark.

It is an integrated company with core competencies in research, development, production, marketing and sales and an international presence in more than 100 markets worldwide and approximately 5900 employees.

Its marketed pharmaceuticals include treatment for Alzheimer?s disease, depression and anxiety, epilepsy, Huntington?s disease, insomnia, Parkinson?s disease, schizophrenia and bipolar disorder.

For further information please visit the website at lundbeck.com

I have done vigorous workouts for years. Just recently, I was diagnosed with Anxiety disorder — after visiting the ER with a whole lot of scary feelings/symptoms.
Since that time, I have had issues with feeling like I can't catch my breath and/or light headedness during certain workouts that are fairly intense. …But although these are tough workouts, they wouldn't have bothered me like this before.
I welcome any input.

There are very few programs that combine state of the art Anxiety Disorder therapies with comprehensive Eating Disorder treatment. not only do we provide both at Castlewood, in addition, trauma resolution therapies are blended when applicable. we are able to treat the Anxiety Disorder, PTSD, and any resulting Dissociative Disorders all while helping clients challenge their Eating Disorder beliefs and behaviors.

Castlewood’s Approach to Anxiety Treatment

by Erin McGinty, LPC

At Castlewood, we believe in treating the underlying causes of our clients’ eating disorders. many of the clients we treat struggle with anxiety disorders in addition to the significant levels of anxiety they experience around eating disorder-related issues such as food, weight, body image, and so on.

In fact, many of our clients struggled with their anxiety disorders even before the eating disorder appeared; some studies have shown that this is true for as many as two-thirds of people struggling with both of an eating disorder and an anxiety disorder (Kaye et al., 2004).

Clients with anxiety disorders who come to Castlewood typically describe their eating disorder and their anxiety to be intricately linked together. Anxiety is among one of the many contributory factors found to be at the root of eating disorder symptoms, and results in higher degrees of perfectionism, obsessionality, avoidance, and body image dissatisfaction among clients who experience both an eating and anxiety disorder (Kaye et al., 2004). Anxiety is also an emotion that our clients have difficulty regulating without using their eating disorder or self-injury, and therefore becomes a trigger for many self-destructive behaviors.

Clients often have had either treatment exclusively for their eating disorder, or only for their anxiety disorder; many have not had treatment for both simultaneously. given the identified links between the two disorders, Castlewood’s treatment philosophy is that both disorders need to be treated at the same time in order to give clients the best chance at long-lasting recovery.

Castlewood utilizes exposure and response prevention therapy, a specific type of cognitive-behavioral therapy, to treat anxiety disorders. Clients are asked to identify anxiety-provoking situations that they typically avoid altogether or have difficulty tolerating without using ritual or harmful behaviors. we then gradually and repetitively expose clients to these situations, while requesting that they not engage in ritual behaviors to cope with the anxiety or fear that they experience. With this consistent exposure to feared situations, clients allow themselves to see that what they fear will happen in a given situation will not actually occur, and as a result their anxiety about a previously feared situation reduces naturally.

In conjunction with exposure and response prevention therapy, Castlewood also utilizes other cognitive and behavioral therapies in the treatment of anxiety disorders that allows us to challenge belief systems that maintain fears and ritual behaviors, as well as to provide clients with alternative skills to help them in managing their anxiety.

Resources:

Kaye, W.H., Bulik, C.M., Thornton, L., Barbarich, N., Masters, K. & Price Foundation Collaborative Group (2004).

Comorbidity of anxiety disorders with anorexia and bulimia nervosa. American Journal of Psychiatry, 161 (12), 2215-2221.

To learn more about how Social Anxiety Disorder impacts Eating Disorder go to:

Social Anxiety Article.

The one sure symptom I am aware of is spending too much time on Yahoo answers.

do you have children?
are they close in age?
do they fight?
do they get started around time for you to prepare supper?
does your husband eat & run leaving you to bath the kids
put them to bed then do the dishes& then shows up wanting sex?
those are my symptoms- i do have more but i hear baby #2 is awake from his nap-gotta go

There's no such diagnosis as "nervous breakdown." It's just a term coined by the entertainment world that seeped over to mainstream society.

If you have anxiety or panic attacks that are interfering with your life, you may have an anxiety disorder. if you are so overwhelmed you want to stay in bed all the time and can't eat or function, you may have depression. if you are hearing voices or seeing things other people don't see, you may have schizophrenia. It could be a hundred other things that make you "break down."

Please talk to a doctor or counselor today. More than likely whatever you have is treatable.

like sweaty palms,heart racing,trembling).

absolutely, those sound like signs of anxiety
If it starts happening frequently you may have an anxiety disorder, then I would suggest seeing a psychiatrist and/or psychologist